A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders

A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency

NCT02311894 ·Status: COMPLETED ·Phase: PHASE4

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

NCT00163189 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

NCT01502124 ·Status: COMPLETED ·Phase: PHASE3

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

NCT05775523 ·Status: RECRUITING

Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

NCT00102817 ·Status: COMPLETED ·Phase: PHASE3

Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin

NCT00488124 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

NCT01009905 ·Status: COMPLETED

Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency.

NCT02229851 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

NCT00557336 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Long-term Somatropin Treatment in Children

NCT01543867 ·Status: COMPLETED

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

NCT02616562 ·Status: COMPLETED ·Phase: PHASE2

Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

NCT00184691 ·Status: COMPLETED ·Phase: PHASE3

Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction

NCT00519844 ·Status: COMPLETED ·Phase: PHASE4

Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

NCT01604161 ·Status: COMPLETED

A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency

NCT02382939 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamics of CNP During Growth Hormone Treatment

NCT01504802 ·Status: COMPLETED

Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children

NCT04513171 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome

NCT00705172 ·Status: COMPLETED

Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)

NCT01438801 ·Status: WITHDRAWN ·Phase: PHASE4

Safety and Efficacy of Long-term Somatropin Treatment in Adults

NCT01543880 ·Status: COMPLETED

Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients

NCT02042170 ·Status: COMPLETED ·Phase: PHASE2

A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9

NCT05723835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

NCT03249480 ·Status: UNKNOWN ·Phase: PHASE4

Acute Application of Pegvisomant and Octreotide in Acromegaly

NCT00595140 ·Status: COMPLETED ·Phase: PHASE4

A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

NCT05330325 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3